Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions

Bokhari, Farasat, Mariuzzo, Franco and Bennato, Anna Rita (2020) Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions. Small Business Economics. ISSN 0921-898X

[img]
Preview
PDF (bbm2014-1-v04e) - Submitted Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[img]
Preview
PDF (Published_Version) - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

New drug introductions are key to growth for pharmaceutical firms. However, not all innovations are the same and they may have differential effects that vary by firm size. We use quarterly sales data on UK pharmaceuticals in a dynamic panel model to estimate the impact of product (new drugs) and marketing (additional pack varieties) innovations within a therapeutic class on a firm’s business unit growth. We find that product innovations lead to substantial growth in both the short and long run, whereas a new pack variety only produces short-term effects. The strategies are substitutes but the marginal effects are larger for product innovations relative to additional packs, and the effects are larger for smaller business units. Nonetheless, pack introductions offer a viable short-term growth strategy, especially for small- and medium-sized businesses.

Item Type: Article
Uncontrolled Keywords: business unit,growth,innovation,pharmaceuticals,size,business, management and accounting(all),economics and econometrics ,/dk/atira/pure/subjectarea/asjc/1400
Faculty \ School: Faculty of Social Sciences > School of Economics
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 05 Dec 2019 02:13
Last Modified: 28 Jul 2020 00:10
URI: https://ueaeprints.uea.ac.uk/id/eprint/73274
DOI: 10.1007/s11187-019-00307-w

Actions (login required)

View Item View Item